---
layout: post
title: "P-Glycoprotein Expression on Patients with Acute Lymphoblastic Leukemia"
author: "R. Niiruri, I. Narayani, K. Ariawati, S. Herawati"
description: "Abstract Objective Pglycoprotein Pgp overexpression on neoplastic cells can deteriorate the therapeutic outcome on cancer patients Pgp plays important role on dru"
categories: jhsm
canonical_url: https://jurnal.harianregional.com/jhsm/id-34823
comments: true
citation_abstract_html_url: "https://jurnal.harianregional.com/jhsm/id-34823"
citation_pdf_url: "https://jurnal.harianregional.com/jhsm/full-34823"
tags:

---

## Authors:
R. Niiruri, I. Narayani, K. Ariawati, S. Herawati

## Abstract:
"Abstract Objective: P-glycoprotein (P-gp) overexpression on neoplastic cells can deteriorate the therapeutic outcome on cancer patients. P-gp plays important role on drug efficacy and toxicity. This research aimed to measure P-gp expression on children with Acute Lymphoblastic Leukemia (ALL) on Sanglah Hospital, Denpasar. Method: Flowcytometry method was used to measure P-gp expression level on Bone Marrow samples from pediatric patients (0-12 years old) who were newly diagnosed with ALL in Sanglah Hospital. P-gp overexpression were based on the percentage of cell stained. Ten percent of P-gp expression were considered as the cut-off value of P-gp overexpression. Result: On this study, 11 samples were obtained with the range value of 56-97% on P-gp expression. Conclusion: All 11 patients had P-gp overexpression."

### Keywords
*Keyword Not Available*

### Downloads:
Download data is not yet available.

{% include adsense.html %}
## References
- REFERENCES
- [1] L. M. Hodges, S. M. Markova, L. W. Chinn, J. M. Gow, D. L.
- Kroetz, T. E. Klein, and R. B. Altman. (2011, March). Very
- important pharmacogene summary: ABCB1 (MDR1, Pglycoprotein).
- Pharmacogenet Genomics. [Online]. 21(3). pp. 152–161. Available:
- https://www.ncbi.nlm.nih.gov/pubmed/20216335
- [2] L. Yan-Hong, W. Yong-Hua, L. Yan, Y. Ling. (2006, February).
- MDR1 Gene Polymorphisms and Clinical Relevance. Acta Genetica
- Sinica. [Online]. 33 (2). pp. 93–104. Available:
- http://www.sciencedirect.com
- /science/article/pii/S0379417206600279?via%3Dihub
- [3] K. L. Fung and M.M. Gotte. (2009, May). A synonymous
- polymorphism in a common MDR1 (ABCB1) haplotype shapes
- protein function. Biochim Biophys Acta. [Online]. 1794(5). pp. 860–
- 871. Available: https://www.ncbi.nlm.nih.gov/pubmed/19285158
- [4] H.J. Broxterman. 1996. How to Probe Clinical Tumour Samples for
- P-glycoprotein and Multidrug Resistance-associated Protein.
- European Journal of Cancer. [Online]. 33A(6). pp. 1024-1033.
- Available: https://www.ncbi.nlm.nih.gov /pubmed/8763344
- [5] A. L. Dogan, A. Kars, H. Canpinar, D. Güç, M. Hayran, W. E. Criss,
- E. Kansu. (2004). Prediction of Clinical Response to Chemotherapy
- by In Vitro Chemosensitivity Assay In Acute Leukemia. Turkish
- Journal of Cancer. [Online]. 34(2). pp. 75-80. Available:
- http://www.turkjcancer.org/pdf/pdf_ TJC_367.pdf
- [6] V. NÜssler, R. Pelka-Flescher, H. Zwierzina, C. Nerl, B. Beckert, F.
- Gieseler, H. Diem, Ledderose G, E. Gullis, H. Sauer, W. Wilmanns.
- > Journal of Health Sciences and Medicine UNUD Journals, Vol. 1 No. 1, February 2017
- 41
- (1996, July). P-glycoprotein expression in patients with acute
- leukemia-clinical relevance. Leukemia. [Online]. 10(Suppl 3). pp.
- S23-S31. Available: https://www.ncbi.nlm.nih.gov/pubmed/8656697
- [7] V. NÜssler, R. Pelka-Flescher, H. Zwierzina, C. Nerl, B. Beckert, E.
- Gullis, F. Gieseler, S. Bock, R. Bartl, P. E. Petrides, et al. (1994).
- Clinical Importance of P-glycoprotein-related resistance in Leukemia
- and Myelodysplastic Syndromes-First Experience with Their
- Reversal. Ann. Hematol. [Online]. 69 (Suppl 1). pp. S25-9.
- Available: http://link.springer.com/article/10.1007/BF01757351
- [8] I B. Mudita. (2007). Pola Penyakit dan Karakteristik Pasien Hemato
- Onkologi Bagian Ilmu Kesehatan Anak Fakultas Kedokteran
- Universitas Udayana / Rumah Sakit Sanglah Periode 2000-2005. Sari
- Pediatri. [Online]. 9(1). pp. 13-16. Available:
- https://www.researchgate.net/publication/312404291_Pola_Penyakit
- _dan_Karakteristik_Pasien_Hemato_Onkologi_Bagian_Ilmu_Keseha
- tan_Anak_Fakultas_Kedokteran_Universitas_UdayanaRS_Sanglah_
- Denpasar_Periode_2000-2005
- [9] S. V. Ambudkar, C. Kimchi-Sarfaty, Z. E. Sauna and M. M.
- Gottesman. (2003). P-glycoprotein: from genomics to mechanism.
- Oncogene. [Online]. 22. pp. 7468–7485. Available:
- https://www.ncbi.nlm.nih.gov/pubmed/14576852
- [10] J. M. Gow, L. M. Hodges, L. W. Chin, D. L. Kroetz. (2008).
- Substrate – Dependent Effect of Human ABCB1 Coding
- Polymorphisms. J Phamacol Exp Ther. [Online]. 325(2). pp. 435 -
- 442. Available: http://jpet.aspetjournals.org/content/jpet/325/2/435.
- full.pdf
- [11] C. Kimchi-Sarfathy, J. M. Oh, I. W. Kim, Z. E. Sauna, A. M.
- Calcagno. S. V. Ambudkar, M. M. Gottesman. (2007). A Silent
- Polymorphism in the MDR-1 Gene Changes Substrate Specificity.
- Science. [Online]. 315. pp. 525-528. Available:
- https://www.ncbi.nlm.nih.gov/pubmed/17185560
- [12] N. N. Salama, Z. Yang, T. Bui, R. J. Ho. (2006). MDR 1 Haplotypes
- Significantly Minimize Intracellular Uptake and Transcellular P-Gp
- Substrate Transport in Recombinant LLC-PK1 Cells. Journal of
- Pharmaceutical Sciences. [Online]. 95. pp. 2293 – 2308. Available:
- https://www.ncbi.nlm.nih.gov/pubmed/16883550
- [13] D. L. Kroetz, C. Pauli-Magnus, L. M. Hodges, C. C. Huang, M.
- Kawamoto, S. J. John, D. Stryke, T. E. Ferrin, J. De Young, T.
- Taylor, E. J. Carlson, I. Herskowitz, K. M. Giacomini, A. G. Clark.
- (2003). Sequence Diversity And Haplotype Structure in Human
- ABCB1 (MDR1, Multi Drug Resistance Transporter) Gene.
- Pharmacogenetics. [Online]. 13. pp. 481-494. Available:
- https://www.ncbi.nlm.nih.gov/pubmed/16883550
- [14] M. K. Leabman, C. C. Huang, J. D. Young, E J. Carlson, T. R.
- Taylor, D. L. M. Cruz, S. J John, D. Stryke, M. Kawamoto, T. J.
- Urban, D. L. Kroetz, T. E. Ferrin, A. G. Clark, N. Risch, I.
- Herskowitz, K. M. Giacomini. (2003). Natural Variation In Human
- Membrane Transpoter Genes Reveals Evolutionary and Functional
- Constrains. Proc Natl Acad Sci USA. [Online]. 100. pp. 5896 – 5901.
- Available: http://www.pnas.org/content/100/10/5896.full.pdf
- [15] S. Hoffmeyer, O. Burk, O Richter, H. P. Arnold, J. Brockmoller, A.
- Johne, I. Cascorbi, T. Gerloff, I. Roots, M. Eichelbaum, U.
- Brinkmann. (2000). Functional polymorphisms of the human
- multidrug resistance gene: multiple sequence variations and
- correlation of one allele with P-glycoprotein expression and activity
- in vivo. Proc NatlAcad Sci USA. [Online]. 97. pp. 3473-3478.
- Available: https://www.ncbi.nlm.nih.gov/pubmed/10716719
- [16] R. B. Kim, B. F. Leake, E. F. Choo, G. K. Dresser, S. V. Kubba, U. I.
- Schwarz, A. Taylor, H. G. Xie, J. McKinsey, S. Zhou, L. B. Lan, J.
- D. Schuetz, E. G. Schuetz, G. R. Wilkinson. (2001). Identification of
- functionally variant MDR1 alleles among European Americans and
- African Americans. Clin Pharmacol Ther. [Online]. 70. pp. 189-199.
- Available: https://www.ncbi.nlm.nih.gov/pubmed/11503014
- [17] M. M. Ameyaw, F. Regateiro, T. Li, X. Liu, M. Tariq, A. Mobarek,
- N. Thornton, G. O. Folayan, J. Githang’a, A. Indalo, D. Ofori-Adjei,
- D. A. Price-Evans, H. L. McLeod. (2001). MDR1 pharmacogenetics:
- frequency of the C3435T mutation in exon 26 is significantly
- influenced by ethnicity. Pharmacogenetics. [Online]. 11. pp. 217-
- 221. Available: https://www.ncbi.nlm.nih.gov/pubmed/11337937
- [18] M. Saidijam, H. Mahjub, N. Shabab, R. Yadegarazari, (2015).
- Simultaneous Analyisis of Multidrug Resistance 1 (MDR-1)
- C3435T, G 2677 T/A, and C1236T Genotype in Hamadan City
- Population, West of Iran. Iranian Biomedical Journal. [Online].
- 19(1). pp. 57-62. Available:
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322234/
- [19] A. J. Brambilla-Tapia. (2013). MDR 1 (ABCB1) polymorphisms:
- functional effects and Clininal Implications. Revista de Investigacon
- Clinica. [Online]. 65(5). pp. 445 –454. Available:
- https://www.ncbi.nlm.nih. gov/pubmed/24687344
- [20] K. Tang, S. M. Ngoi, P. C. Gwee, J. M. Chua, E. J. Lee, S. S. Chong
- and C. G. Lee. (2002). Distinct Haplotype Profiles And Strong
- Linkage Disequilibrium At The MDR1 Multidrug Transporter Gene
- Locus In Three Ethnic Asian Populations. Pharmacogenetics.
- [Online]. 12. pp. 437–450. Available:https://www.ncbi.nlm.nih.gov/
- pubmed/12172212
- [21] C. J. Chen, D. Clark, K. Ueda, I. Pastan, M. M. Gottesman and I. B.
- Roninson. (1990, January). Genomic Organization of Human
- Multidrug Resistance (MDR1) Gene and Origin of P-Glycoprotein. J
- Biol Chem. [Online]. 265(1). pp. 506-514. Available:
- https://www.ncbi.nlm.nih.gov/pubmed/1967175
- [22] D. Vivona, L. T. Lima, A. C. Rodrigues, C. T. Bueno, G. K. S.
- Alcantara, L. S. R. Barbos, V. T. D. M. Hungria, C. S. Chiattone, M.
- D. L. L. D. Chauffaille, E. M. Guerra-Shinohara. (2014). ABCB1
- Haplotype are Associated with P-gp Activity and Affect a Major
- Molecular Response in Chronic Myeloid Leukemia Patients Treated
- with A standard Dose of Imatinib. Oncology Letters. [Online]. 7. pp.
- 1313-1319. Available: https://www.ncbi.nlm.nih.gov/pubmed/24660
- 038
- [23] K. L. Fung and M. M. Gottesman. (1794). A synonymous
- polymorphism in a common MDR1 (ABCB1) haplotype shapes
- protein function. Biochim Biophys Acta. 1794. pp. 860-871.
- [24] A. Ashariati, (2008, October). Polymorphism C3435T of The MDR-
- 1 Gene Predict Response to Preoperative Chemotherapy in Locally
- Advanced Breast Cancer with Her 2/ neu Expression. Acta med
- Indones, [Online]. 40(4). pp. 187-91. Available:
- https://www.ncbi.nlm.nih.gov/pubmed/19151448
- [25] A. F. List, K. J. Kopecky, C. L. Willman, D. R. Head, D. L. Persons,
- M. L. Slovak, R. Dorr, C. Karanes, H. E. Hynes, J. H. Doroshow, M.
- Shurafa and F. R. Appelbaum. (2001). Benefit of cyclosporine
- modulation of drug resistance in patients with poor-risk acute
- myeloid leukemia: a Southwest Oncology Group study. Blood,
- [Online]. 98. pp. 3212–3220. Available:
- https://www.ncbi.nlm.nih.gov/pubmed ?cmd=Link &dbFrom
- =PubMed&from_uid=8874180

### PDF:

{% include adsense1.html %}

<https://jurnal.harianregional.com/jhsm/full-34823>

{% include adsense2.html %}

### Published
2017-02-01

### How To Cite
NIIRURI, R. et al.  P-Glycoprotein Expression on Patients with Acute Lymphoblastic Leukemia.Journal of Health Sciences and Medicine, [S.l.], v. 1, n. 1, p. 39-41, feb. 2017. ISSN 2622-0555. Available at: <https://ojs.unud.ac.id/index.php/JHSM/article/view/34823>. Date accessed: {{ site.time | date: "%d %b. %Y" }}. doi:https://doi.org/10.24843/JHSM.2017.v01.i01.p10.

## Citation Format
ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian

### Issue
Vol 1 No 1 (2017): JHSM (Febuary 2017)

### Section 
**Articles**

### Copyright 
{% include inarticle.html %}
<a href="http://creativecommons.org/licenses/by/4.0/" rel="license"><img src="https://i.creativecommons.org/l/by/4.0/88x31.png" alt="Creative Commons License" /></a>
This work is licensed under a <a href="http://creativecommons.org/licenses/by/4.0/" rel="nofollow">Creative Commons Attribution 4.0 International License</a>

{% include multiplex.html %}
